SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: J Stone who wrote (26903)12/14/1998 6:34:00 PM
From: bob zagorin  Respond to of 32384
 
Don't know but everyone else posts about other biotechs as well as anything else under the sun. We've talked a lot about the size of markets that LGND and others address. Can't be many larger markets than asthma.



To: J Stone who wrote (26903)12/15/1998 8:59:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
LGND has an IL-4 program that targets asthma:

Message 3916768


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News